Immunoblotting analysis of clinical colorectal cancer samples revealed that KDM6A expression was markedly reduced in CAFs compared to non-activated fibroblasts (NAFs) from the adjacent non-cancerous tissue. Here, KDM6A is linked to colorectal cancer.